# Ezetimibe/Simvastatin Combination in Proteinuric Nephropathy

> **NCT00861731** · PHASE4 · UNKNOWN · sponsor: **Azienda Ospedaliero Universitaria di Sassari** · enrollment: 30 (estimated)

## Conditions studied

- Hypercholesterolemia
- Chronic Nephropathy

## Interventions

- **DRUG:** simvastatin
- **DRUG:** EZE/simvastatin
- **DRUG:** EZE/simvastatin

## Key facts

- **NCT ID:** NCT00861731
- **Lead sponsor:** Azienda Ospedaliero Universitaria di Sassari
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-11
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2009-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00861731

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00861731, "Ezetimibe/Simvastatin Combination in Proteinuric Nephropathy". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00861731. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*